<DOC>
	<DOCNO>NCT00781521</DOCNO>
	<brief_summary>This pilot study determine safety effectiveness twice daily , seven-day dose regimen acute , pediatric , otitis medium child tympanostomy tube . The currently approve regimen twice daily 10 day .</brief_summary>
	<brief_title>Safety Efficacy Floxin Otic Solution Treatment Acute Otitis Media Children</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<criteria>Male female 6 month age &lt; 12 year age weight = &gt; 4.5 kg Patent tympanostomy tube ( ) affect ear ( ) Purulent mucopurulent otorrhea recent onset presume bacterial origin Nonbacterial otic infection Known suspect hypersensitivity ofloxacin Cystic fibrosis HIV infection Neutropenia Receiving immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>